GBP, AN INHIBITOR OF GSK-3, IS IMPLICATED IN XENOPUS DEVELOPMENT AND ONCOGENESIS

Citation
C. Yost et al., GBP, AN INHIBITOR OF GSK-3, IS IMPLICATED IN XENOPUS DEVELOPMENT AND ONCOGENESIS, Cell, 93(6), 1998, pp. 1031-1041
Citations number
66
Categorie Soggetti
Biology,"Cell Biology
Journal title
CellACNP
ISSN journal
00928674
Volume
93
Issue
6
Year of publication
1998
Pages
1031 - 1041
Database
ISI
SICI code
0092-8674(1998)93:6<1031:GAIOGI>2.0.ZU;2-K
Abstract
Dorsal accumulation of beta-catenin in early Xenopus embryos is requir ed for body axis formation. Recent evidence indicates that beta-cateni n is dorsally stabilized by the localized inhibition of the kinase Xgs k-3, utilizing a novel Wnt ligand-independent mechanism. Using a two-h ybrid screen, we identified GBP, a maternal Xgsk-3-binding protein tha t is homologous to a T cell protooncogene in three well-conserved doma ins. GBP inhibits in vivo phosphorylation by Xgsk-3, and ectopic GBP e xpression induces an axis by stabilizing beta-catenin within Xenopus e mbryos. Importantly, antisense oligonucleotide depletion of the matern al GBP mRNA demonstrates that GBP is required for the establishment of the dorsal-ventral axis in Xenopus embryos. Our results define a fami ly of GSK-3-binding proteins with roles in development and cell prolif eration.